Detection of Disseminating Tumor Cells (DTCs) holds promise for the early detection of potential relapse. The presence of bone marrow DTCs correlate with increased relapse risk, decreasing overall survival. Applied Cells, a commercial provider of cell preparation and isolation solutions
Santa Clara – December 2, 2020 – Applied Cells, Inc., announced today that the company will unveil its MARS® Bar System, a revolutionary fully automated high-capacity closed system for cell processing, for Early Access Program. The MARS® Bar system enables
We are pleased to announce that we have won the CYTO 2020 Technology Innovation Award at Virtual CYTO, 2020. ISAC, the International Society for the Advancement of Cytometry, held its annual CYTO meeting August 4-5, 2020. The virtual exhibit had
SANTA CLARA, Calif., Jan. 20, 2020 University of Pennsylvania (Penn) and Applied Cells Inc., a Santa Clara, California based biotechnology company, announced today that they have entered into a Collaborative Research Agreement to evaluate Applied Cells new generation cell isolation and sample
AACR Virtual
April 10-14
Immunology Virtual 2021
May 10-14
CYTO Virtual Interactive
June 7-10